Holen Sie sich die Stockscreener-App
3.75
0.53%
-0.02
Vorhandelsmarkt:
3.77
0.02
+0.53%
Schlusskurs vom Vortag:
$3.77
Offen:
$3.82
24-Stunden-Volumen:
6.92M
Relative Volume:
1.24
Marktkapitalisierung:
$1.68B
Einnahmen:
$1.70B
Nettoeinkommen (Verlust:
$-123.70M
KGV:
-14.08
EPS:
-0.2663
Netto-Cashflow:
$-178.21M
1W Leistung:
+12.95%
1M Leistung:
+8.07%
6M Leistung:
+9.97%
1J Leistung:
+330.74%
1-Tages-Spanne:
$3.71
$3.89
1-Wochen-Bereich:
$3.25
$3.90
52-Wochen-Spanne:
$0.7879
$4.87
Clover Health Investments Corp Stock (CLOV) Company Profile
Firmenname
Clover Health Investments Corp
Sektor
Branche
Telefon
(201) 432-2133
Adresse
3401 MALLORY LANE, SUITE 210, FRANKLIN
Vergleichen Sie CLOV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLOV
Clover Health Investments Corp
|
3.75 | 1.68B | 1.70B | -123.70M | -178.21M | -0.2663 |
|
UNH
Unitedhealth Group Inc
|
385.55 | 548.34B | 410.06B | 22.11B | 24.86B | 23.88 |
|
ELV
Elevance Health Inc
|
412.38 | 92.25B | 183.12B | 5.92B | 3.67B | 25.63 |
|
CI
Cigna Group
|
333.11 | 89.54B | 254.47B | 5.03B | 6.01B | 18.06 |
|
CVS
Cvs Health Corp
|
67.85 | 87.86B | 378.96B | 5.28B | 5.94B | 4.19 |
|
HUM
Humana Inc
|
253.35 | 30.90B | 117.76B | 1.21B | 2.39B | 9.95 |
Clover Health Investments Corp Stock (CLOV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-17 | Eingeleitet | Craig Hallum | Buy |
| 2024-10-07 | Eingeleitet | UBS | Neutral |
| 2022-02-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-02-02 | Hochstufung | Cowen | Underperform → Market Perform |
| 2022-01-19 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2022-01-10 | Fortgesetzt | Citigroup | Neutral |
| 2022-01-07 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Underperform |
| 2021-09-02 | Fortgesetzt | Citigroup | Neutral |
| 2021-07-12 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-06-10 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-05-17 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-03-09 | Eingeleitet | Credit Suisse | Neutral |
| 2021-02-02 | Eingeleitet | Citigroup | Buy |
| 2021-02-01 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Clover Health Investments Corp Aktie (CLOV) Neueste Nachrichten
Clover Health Investments And 2 Other Growth Stocks With Strong Insider Confidence - simplywall.st
Clover Health Investments, Corp. (NASDAQ:CLOV) Could Be Riskier Than It Looks - simplywall.st
Analysts Are Updating Their Clover Health Investments, Corp. (NASDAQ:CLOV) Estimates After Its First-Quarter Results - simplywall.st
CLOV Stock Rises as Q1 Earnings Beat Estimates, Revenues Up Y/Y - MSN
Clover Health targets 30% Medicare Advantage growth and raises 2025 EBITDA guidance - MSN
Clover Health’s Earnings Call Highlights Growth and Optimism - TipRanks
Clover Health Shares Surge After Strong Q1 Earnings, Now Up 409% Over Past Year - Benzinga
Clover Health Investments: Strong Performance and Growth Potential Justify Buy Rating - TipRanks
Clover Health Investments, Corp. (NASDAQ:CLOV) Q1 2025 Earnings Call Transcript - Insider Monkey
Clover Health Investments Corp (CLOV) Q1 2025 Earnings Call Highlights: Record Growth in ... - Yahoo Finance
Clover Health Investments Corp (CLOV) Q1 2025 Earnings Call High - GuruFocus
Clover Health Investments Corp (CLOV) Q1 2025 Earnings Call Highlights: Record Growth in Revenue and Membership - GuruFocus
Clover Health Sees Strong Growth in Q1 2025 - TipRanks
Clover Health (CLOV) Sees Strong Growth in Q1 2025 - GuruFocus
Clover Health Investments earnings beat by $0.09, revenue fell short of estimates By Investing.com - Investing.com
Clover Health Investments, Corp. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:CLOV) - Seeking Alpha
Earnings call transcript: Clover Health’s Q1 2025 revenue surges, stock ticks up - Investing.com
Clover Health Investments, Corp. (CLOV) Surpasses Q1 Earnings Estimates - Yahoo Finance
Clover Health (CLOV) Delivers Strong Q1 2025 Financial Performance | CLOV Stock News - GuruFocus
CLOV Reports Q1 Revenue Slightly Below Expectations Amid Growth in Membership | CLOV Stock News - GuruFocus
Clover Health (CLOV) Reports Strong Profit Growth Despite Revenue Miss - GuruFocus
Clover Health Q1 2025 slides: Revenue surges 34%, adjusted EBITDA up 279% - Investing.com
Clover Health (CLOV) Q1 2025 Earnings: EPS of -$0.07 Meets Estimates, Revenue of $462M Misses Expectations - GuruFocus
Earnings Flash (CLOV) Clover Health Investments Reports Q1 Revenue $462M, vs. FactSet Est of $466.9M - marketscreener.com
Clover Health Reports First Quarter 2025 Results and Improves Full Year 2025 Guidance - The Manila Times
CLOV Anticipates Higher Volatility Ahead of Earnings Release | CLOV Stock News - GuruFocus
Clover Health (NASDAQ:CLOV) Misses Q1 Sales Targets - Barchart.com
Tech That Listens, Learns, and Diagnoses: AI's Breakout Moment in Healthcare - Quantisnow
Clover Health (CLOV) Prepares for Q1 Earnings with Revenue Growt - GuruFocus
Clover Health (CLOV) Prepares for Q1 Earnings with Revenue Growth Expectations - GuruFocus
Clover Health Reports Fourth Quarter and Full Year 2024 Results; Provides Full Year 2025 Guidance - ADVFN
Watch These 3 MedTech Stocks for Q1 Earnings: Beat or Miss? - TradingView
Clover Health: Compelling Strategy, Challenging Financials (NASDAQ:CLOV) - Seeking Alpha
Clover Health Investments Corp (CLOV) Q1 2025 Earnings Report Preview: What To Look For - GuruFocus
Form 8-KCurrent report - ADVFN
3 Cash-Heavy Stocks Skating on Thin Ice - The Globe and Mail
Primary Care Physician Use of Counterpart Assistant Technology Associated with Better Health Outcomes in Patients with Congestive Heart Failure - The Manila Times
Breakthrough AI Study: How Clover Health's Tech Slashed Heart Failure Hospitalizations by 25% in Medicare Patients - Stock Titan
New Advances in Healthcare AI Could Unlock Billions in Market Opportunity - The Malaysian Reserve
2 Healthcare Stocks On Our Watchlist And 1 To Be Wary Of - Barchart.com
Press Release Distribution & PR Platform - ACCESS Newswire
Clover Health Reports Strong Third Quarter 2024 Financial Results; Highlights Differentiated Market Opportunity to Grow Membership - ADVFN
10 Best Multibagger Penny Stocks to Buy According to Billionaires - Insider Monkey
Is Clover Health Investments, Corp. (CLOV) the Best Multibagger Penny Stock to Buy According to Billionaires? - Insider Monkey
Clover Health board member to exit, successor named By Investing.com - Investing.com South Africa
Clover Health board member to exit, successor named - Investing.com
Clover Health Announces Changes to Board of Directors - TradingView
Clover Health's Audit Committee Chief Exits for American Heart Association Leadership: Key Board Changes Revealed - Stock Titan
Qualcomm Exceeds Expectations, Rises 8%; Wolfspeed Drops 25% on Negative Margin; Lyft and AppLovin Surge Over 20% - ADVFN
Clover Health to Participate in Upcoming Investor Conferences - The Manila Times
Clover Health to Participate in Upcoming Investor Conferences | CLOV Stock News - GuruFocus
Finanzdaten der Clover Health Investments Corp-Aktie (CLOV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.21%
0.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):